Introduction and purpose: Pancreatic adenocarcinoma (PAC) is the third most common cancer of the gastrointestinal tract in the Western population. Peritoneal metastases (PM) affect 5-10% patients with PAC at the moment of diagnosis and 50% of patients who experience a recurrence after a successful resection. This review aims to evaluate the efficacy of pressurized intraperitoneal aerosol chemotherapy (PIPAC) in the treatment of PM from PAC based on the literature available on PubMed websiteBrief description of the state of knowledge: PIPAC is a relatively new method of treatment and the number of studies investigating its application in the treatment of PM from PAC is scarce. Nevertheless, initial findings suggest that PIPAC is linked to 15...
Background: The survival prognosis of patients with peritoneal metastasis (PM) of gastrointestinal (...
Background. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) has been introduced as a novel ...
Background: Few patients affected by gastric cancer peritoneal metastasis (GCPM) are offered locoreg...
Introduction and purpose: Pancreatic adenocarcinoma (PAC) is the third most common cancer of the gas...
INTRODUCTION: Systemic chemotherapy offers poor control over peritoneal disease, maybe as a conseque...
Background: Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is a novel intraperitoneal drug...
Background: Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is a laparoscopy-guided adminis...
\(\bf Background\) Patients suffering from peritoneal carcinomatosis of pancreatic adenocarcinoma w...
INTRODUCTION Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is a treatment option for p...
Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is an emerging palliative treatment for pat...
Objective:. The objective of this study is to analyze oncological outcomes of patients with peritone...
Recently, a novel method for chemotherapy administration inside the abdominal cavity gained wide at...
Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is a minimally invasive approach under inve...
BACKGROUND: Peritoneal malignancies include primary and metastatic cancer of the peritoneal cavity. ...
Aim: Gastric cancer is the cancer with the highest rate of peritoneal metastization and this type of...
Background: The survival prognosis of patients with peritoneal metastasis (PM) of gastrointestinal (...
Background. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) has been introduced as a novel ...
Background: Few patients affected by gastric cancer peritoneal metastasis (GCPM) are offered locoreg...
Introduction and purpose: Pancreatic adenocarcinoma (PAC) is the third most common cancer of the gas...
INTRODUCTION: Systemic chemotherapy offers poor control over peritoneal disease, maybe as a conseque...
Background: Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is a novel intraperitoneal drug...
Background: Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is a laparoscopy-guided adminis...
\(\bf Background\) Patients suffering from peritoneal carcinomatosis of pancreatic adenocarcinoma w...
INTRODUCTION Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is a treatment option for p...
Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is an emerging palliative treatment for pat...
Objective:. The objective of this study is to analyze oncological outcomes of patients with peritone...
Recently, a novel method for chemotherapy administration inside the abdominal cavity gained wide at...
Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is a minimally invasive approach under inve...
BACKGROUND: Peritoneal malignancies include primary and metastatic cancer of the peritoneal cavity. ...
Aim: Gastric cancer is the cancer with the highest rate of peritoneal metastization and this type of...
Background: The survival prognosis of patients with peritoneal metastasis (PM) of gastrointestinal (...
Background. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) has been introduced as a novel ...
Background: Few patients affected by gastric cancer peritoneal metastasis (GCPM) are offered locoreg...